These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17010462)

  • 61. Energy drink ingredients. Contribution of caffeine and taurine to performance outcomes.
    Peacock A; Martin FH; Carr A
    Appetite; 2013 May; 64():1-4. PubMed ID: 23313701
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dysgraphia in children: lasting psychomotor deficiency or transient developmental delay?
    Smits-Engelsman BC; Van Galen GP
    J Exp Child Psychol; 1997 Nov; 67(2):164-84. PubMed ID: 9388804
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Faster but not smarter: effects of caffeine and caffeine withdrawal on alertness and performance.
    Rogers PJ; Heatherley SV; Mullings EL; Smith JE
    Psychopharmacology (Berl); 2013 Mar; 226(2):229-40. PubMed ID: 23108937
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intentional control and biomechanical exploitation in preparatory handwriting.
    Bosga-Stork IM; Bosga J; Meulenbroek RG
    Hum Mov Sci; 2011 Aug; 30(4):687-97. PubMed ID: 21256611
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adapting to the surface: A comparison of handwriting measures when writing on a tablet computer and on paper.
    Gerth S; Dolk T; Klassert A; Fliesser M; Fischer MH; Nottbusch G; Festman J
    Hum Mov Sci; 2016 Aug; 48():62-73. PubMed ID: 27132154
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
    García-Gea C; Martínez-Colomer J; Antonijoan RM; Valiente R; Barbanoj MJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Temporal modulations of agonist and antagonist muscle activities accompanying improved performance of ballistic movements.
    Liang N; Yamashita T; Ni Z; Takahashi M; Murakami T; Yahagi S; Kasai T
    Hum Mov Sci; 2008 Feb; 27(1):12-28. PubMed ID: 17936390
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Influence of personality traits on reaction performance in volunteers after a single administration of placebo, crotylbarbital and caffeine].
    Meyer FP; Walther T; Walther H
    Pharmacopsychiatria; 1983 Jan; 16(1):13-8. PubMed ID: 6131448
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Caffeine effects on resting-state arousal in children.
    Barry RJ; Clarke AR; Johnstone SJ; Brown CR; Bruggemann JM; van Rijbroek I
    Int J Psychophysiol; 2009 Sep; 73(3):355-61. PubMed ID: 19486913
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Remembering the orientation of newly learned characters depends on the associated writing knowledge: a comparison between handwriting and typing.
    Longcamp M; Boucard C; Gilhodes JC; Velay JL
    Hum Mov Sci; 2006 Oct; 25(4-5):646-56. PubMed ID: 17011660
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reproducibility and minimal detectable change of three-dimensional kinematic analysis of reaching tasks in people with hemiparesis after stroke.
    Wagner JM; Rhodes JA; Patten C
    Phys Ther; 2008 May; 88(5):652-63. PubMed ID: 18326055
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impairment of complex upper limb motor function in de novo Parkinson's disease.
    Ponsen MM; Daffertshofer A; Wolters ECh; Beek PJ; Berendse HW
    Parkinsonism Relat Disord; 2008; 14(3):199-204. PubMed ID: 17913560
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Caffeine, cycling performance, and exogenous CHO oxidation: a dose-response study.
    Desbrow B; Barrett CM; Minahan CL; Grant GD; Leveritt MD
    Med Sci Sports Exerc; 2009 Sep; 41(9):1744-51. PubMed ID: 19657295
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J; Trick L; Johnsen S; Roach J; Rubens R
    Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Kinematic analysis of dopaminergic effects on skilled handwriting movements in Parkinson's disease.
    Tucha O; Mecklinger L; Thome J; Reiter A; Alders GL; Sartor H; Naumann M; Lange KW
    J Neural Transm (Vienna); 2006 May; 113(5):609-23. PubMed ID: 16082511
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Muscle Activity during Handwriting on a Tablet: An Electromyographic Analysis of the Writing Process in Children and Adults.
    Gerth S; Festman J
    Children (Basel); 2023 Apr; 10(4):. PubMed ID: 37189997
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cognitive performance during sustained wakefulness: A low dose of caffeine is equally effective as modafinil in alleviating the nocturnal decline.
    Dagan Y; Doljansky JT
    Chronobiol Int; 2006; 23(5):973-83. PubMed ID: 17050212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.